Nexplanon Removal: Subcutaneous vs. Topical Lidocaine

Status unconfirmed · Phase 4

Conditions studied: Contraception

In brief

A randomized trial of using EMLA cream for anesthesia to remove Nexplanon versus the standard route of subcutaneous lidocaine for anesthesia. Primary endpoints are pain during procedure and time to removal.

Key facts

Study ID

NCT04467125

Run by

Augusta University

People needed

40

Starts

2020-01-06

Expected to finish

2023-05-31

Last updated by the study team

2020-07-10

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Females with Nexplanon implant in place, desiring removal No allergy to lidocaine or any component of EMLA cream Age greater than or equal to 18years English as primary language Not pregnant

You may not qualify if…

• pregnant non-emglish speaking age less than 18 yo Allergy to lidocaine or EMLA

Where it is running

• Augusta University Ob/Gyn Resident Continuity Clinic — Augusta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.